Linked infacebooktwitteryoutube
Qure.ai

Qure.ai, Global Healthcare AI Leader, Raises $65 Million in Series D Funding Led by Lightspeed and 360 ONE Asset

Centogene

CENTOGENE Unveils Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet Neurology

AmoyDx

AmoyDx Pan Lung Cancer PCR Panel Approved as Companion Diagnostic for Repotrectinib in Advanced NSCLC

Eli Lilly

Lilly's Kisunla™ (donanemab-azbt) Gains Approval in Japan for Early Symptomatic Alzheimer's Disease Treatment

Roche

Roche Launches 12-Virus Diagnostic Test Across Europe

J.P. Nadda

Government to Launch Program to Develop 12 Indigenous Drugs Targeting 8 Rare Diseases

GRM Information Management

GRM Information Management and HistoWiz Expand Partnership with HistoWiz Joining GRM as a Client

AstraZeneca Pharma India Limited

AstraZeneca India Receives CDSCO Approval for Expanded Indications of Its Chemotherapy Drug

HCG Manavata Cancer Centre

HCGMCC Introduces Vansham Clinic to Promote Hereditary Cancer Awareness and Provide Lifesaving Family Screenings

WHO

WHO Updates Cervical Cancer Guidelines to Incorporate Roche’s Dual-Stain Test

Complete Genomics

AdvancedDx Biological Laboratories and Complete Genomics Form Partnership for NGS-Based Infectious Disease Assays

MOC Cancer Care & Research Centre

MOC Cancer Care & Research Centre Unveils CAR-T Cell Therapy

Gene Therapy

CJI Calls for Universal Access to Gene Therapy

Cervical cancer

Quad Cancer Moonshot: A United Effort to Eliminate Cervical Cancer in the Indo-Pacific

ICGA

ICGA Launches India's First Open-Access Cancer Data Portal to Advance Personalized Treatment